Symmetry Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-563
| Closed | -$223K | – | 551 |
|
|
2024
Q1 | $223K | Buy |
+563
| New | +$223K | 0.02% | 508 |
|
|
2023
Q4 | – | Sell |
-563
| Closed | -$211K | – | 560 |
|
|
2023
Q3 | $211K | Sell |
563
-158
| -22% | -$59.2K | 0.01% | 508 |
|
|
2023
Q2 | $276K | Hold |
721
| – | – | 0.01% | 486 |
|
|
2023
Q1 | $250K | Sell |
721
-1,071
| -60% | -$371K | 0.01% | 486 |
|
|
2022
Q4 | $422K | Sell |
1,792
-1,271
| -41% | -$299K | 0.03% | 377 |
|
|
2022
Q3 | $754K | Hold |
3,063
| – | – | 0.05% | 217 |
|
|
2022
Q2 | $926K | Hold |
3,063
| – | – | 0.06% | 183 |
|
|
2022
Q1 | $1.26M | Hold |
3,063
| – | – | 0.08% | 159 |
|
|
2021
Q4 | $1.44M | Hold |
3,063
| – | – | 0.09% | 142 |
|
|
2021
Q3 | $1.27M | Hold |
3,063
| – | – | 0.08% | 165 |
|
|
2021
Q2 | $1.1M | Hold |
3,063
| – | – | 0.07% | 206 |
|
|
2021
Q1 | $863K | Sell |
3,063
-11
| -0.4% | -$3.1K | 0.06% | 236 |
|
|
2020
Q4 | $871K | Buy |
3,074
+3
| +0.1% | +$850 | 0.07% | 215 |
|
|
2020
Q3 | $844K | Buy |
3,071
+729
| +31% | +$200K | 0.07% | 202 |
|
|
2020
Q2 | $532K | Buy |
2,342
+263
| +13% | +$59.7K | 0.07% | 136 |
|
|
2020
Q1 | $317K | Buy |
+2,079
| New | +$317K | 0.07% | 195 |
|